Diversity Libraries

High-impact drug discovery screening libraries of 5k–400k diverse compounds engineered for breakthrough hit discovery.

AQura Bio’s 2M+ Screening Collection and 400k+ qualified Building Blocks provide a robust foundation for small-molecule hit identification. The collection is continuously expanded with structurally novel chemotypes arising from advanced synthetic methodologies, enabling broader exploration of chemical space and improving the likelihood of identifying tractable, high-quality hits across diverse target classes.

Our Diversity Libraries are rigorously curated using medicinal-chemistry principles, including scaffold diversity, lead-like physicochemical parameters, property-balanced design, and minimization of structural redundancy. Each library is built to offer maximal chemical-space coverage and high hit relevance, supporting both broad high-throughput screening (HTS) and targeted discovery campaigns. Libraries span drug-like, lead-like, and fragment-like subsets, facilitating efficient progression from primary hits to optimizable lead series with favourable developability profiles.

Contact us for further information.